Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMB Research
Boston, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CMB, formerly known as Chadwick Martin Bailey, is a U.S.-based custom market research and strategy consulting firm rather than a biotech, pharma, or healthcare operating company. The firm provides data-driven market strategy, advanced analytics, qualitative research, brand health, customer journey, loyalty, and innovation services to commercial clients across multiple industries, including healthcare. CMB appears to be active as a brand and business unit, but it was acquired by ITA Group effective September 1, 2017. Based on the available public information, CMB does not develop therapeutics, run a drug pipeline, or operate as a life sciences company.
- Industry
- Consulting
Beyond the preview
Go deeper on CMB Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CMB Research.